← All trials
NCT05519683
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 2, 2022
- Primary completion
- Sep 30, 2025
- Completion date
- Sep 30, 2025
- First posted
- Aug 29, 2022
- Last posted
- Dec 5, 2022
- Enrollment
- 160
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of MichiganLead sponsor
- National Center for Complementary and Integrative Health (NCCIH)Collaborator
- National Institute of Neurological Disorders and Stroke (NINDS)Collaborator
- University of MichiganOverall official - principal investigator
- University of MichiganReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.